Literature DB >> 16934195

Hemodynamic management of septic shock.

Daniel De Backer1.   

Abstract

Septic shock is characterized by profound cardiovascular alterations, including hypovolemia, severe alterations in vascular tone, and myocardial depression. These effects can lead to tissue hypoperfusion, the persistence of which could contribute to multiple organ failure. In addition, regional blood flow alterations and microvascular blood flow alterations may coexist and persist even after whole body hemodynamic alterations are corrected. Early aggressive interventions to improve oxygen delivery have been shown to improve outcome, but ongoing hemodynamic support is often required. This review will examine the hemodynamic management of patients with septic shock.

Entities:  

Year:  2006        PMID: 16934195     DOI: 10.1007/s11908-006-0047-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  57 in total

1.  Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation.

Authors:  Mervyn Singer; Vincenzo De Santis; Domenico Vitale; William Jeffcoate
Journal:  Lancet       Date:  2004 Aug 7-13       Impact factor: 79.321

2.  A single dose of endotoxin increases intestinal permeability in healthy humans.

Authors:  S T O'Dwyer; H R Michie; T R Ziegler; A Revhaug; R J Smith; D W Wilmore
Journal:  Arch Surg       Date:  1988-12

Review 3.  The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction.

Authors:  M G Mythen; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

4.  Nitroglycerin in septic shock after intravascular volume resuscitation.

Authors:  Peter E Spronk; Can Ince; Martin J Gardien; Keshen R Mathura; Heleen M Oudemans-van Straaten; Durk F Zandstra
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

5.  Temporal hemodynamic and oxygen transport patterns in medical patients. Septic shock.

Authors:  W C Shoemaker; P L Appel; H B Kram; M H Bishop; E Abraham
Journal:  Chest       Date:  1993-11       Impact factor: 9.410

6.  Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock.

Authors:  Yasser Sakr; Marc-Jacques Dubois; Daniel De Backer; Jacques Creteur; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2004-09       Impact factor: 7.598

7.  Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients.

Authors:  G Gutierrez; F Palizas; G Doglio; N Wainsztein; A Gallesio; J Pacin; A Dubin; E Schiavi; M Jorge; J Pusajo
Journal:  Lancet       Date:  1992-01-25       Impact factor: 79.321

8.  Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats.

Authors:  C M Pastor; T R Billiar
Journal:  Am J Physiol       Date:  1995-01

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

Review 10.  Renal blood flow in sepsis.

Authors:  Christoph Langenberg; Rinaldo Bellomo; Clive May; Li Wan; Moritoki Egi; Stanislao Morgera
Journal:  Crit Care       Date:  2005-05-24       Impact factor: 9.097

View more
  2 in total

1.  Vasodilating prostaglandin E1 does not reproduce interleukin-1β-induced oxygen metabolism abnormalities in rabbits.

Authors:  Shigenari Matsuyama; Koichi Hayakawa; Kazuhito Sakuramoto; Takashi Muroya; Yasushi Nakamori; Hitoshi Ikegawa; Takeshi Shimazu; Yasuyuki Kuwagata
Journal:  Acute Med Surg       Date:  2014-10-22

Review 2.  Septic encephalopathy.

Authors:  Marek Ziaja
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.